<![CDATA[Biotek-snakken — December 2019]]>God morgen. 🙂

]]>https://dev.proinvestor.com/forum/topic/401390/biotek-snakken-december-2019RSS for NodeMon, 08 Jun 2026 04:15:28 GMTSun, 01 Dec 2019 04:33:43 GMT60<![CDATA[Reply to Biotek-snakken — December 2019 on Tue, 31 Dec 2019 07:35:55 GMT]]>Godt nytår: https://www.proinvestor.com/index.php?p=debat_1&postid=80495

]]>https://dev.proinvestor.com/forum/post/8057758https://dev.proinvestor.com/forum/post/8057758Tue, 31 Dec 2019 07:35:55 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 30 Dec 2019 05:29:12 GMT]]>God morgen. 🙂

]]>https://dev.proinvestor.com/forum/post/8057756https://dev.proinvestor.com/forum/post/8057756Mon, 30 Dec 2019 05:29:12 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Sat, 28 Dec 2019 14:31:58 GMT]]>🙂

]]>https://dev.proinvestor.com/forum/post/8057754https://dev.proinvestor.com/forum/post/8057754Sat, 28 Dec 2019 14:31:58 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Tue, 24 Dec 2019 08:52:41 GMT]]>Enochian: https://www.proinvestor.com/investornyt/651825/enochian-20-ned-efter-teknisk-brud-af-stottelinje

]]>https://dev.proinvestor.com/forum/post/8057755https://dev.proinvestor.com/forum/post/8057755Tue, 24 Dec 2019 08:52:41 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 16:48:01 GMT]]>Har kigget lidt på Sutro og købt en slat - mest grundet Ohad Hammer nævnte den, så følger jeg mere op på den løbende og køber evt mere senere hen. Som han skriver nok først efter de første data fra deres ADC paltform. I forhold til andre biotekselskaber er den værdisat rimeligt

]]>https://dev.proinvestor.com/forum/post/8057752https://dev.proinvestor.com/forum/post/8057752Mon, 23 Dec 2019 16:48:01 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 16:46:34 GMT]]>Ja IND fra Merck må der også være chance for sent i Q1 eller i Q2, hvis alt går vel - fedt hvis 2020 bliver året med helt op til 4 BsAbs i klinikken fra partnerne.

]]>https://dev.proinvestor.com/forum/post/8057753https://dev.proinvestor.com/forum/post/8057753Mon, 23 Dec 2019 16:46:34 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 16:22:03 GMT]]>Nyt fra Fortress biohttps://newsfilter.io/articles/fortress-bio-in-licenses-rights-for-astrazenecas-azd7325-85fc2b7da215a5f54f302777dd1cf129

]]>https://dev.proinvestor.com/forum/post/8057750https://dev.proinvestor.com/forum/post/8057750Mon, 23 Dec 2019 16:22:03 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 14:41:16 GMT]]>Forresten, har du kigget på Sutro Biopharma? Ohad Hammer nævner dem i sit nye blog-indlæg, de har et par fine collaborations med BP og forsøger sig med ADC med site specific conjugation

]]>https://dev.proinvestor.com/forum/post/8057759https://dev.proinvestor.com/forum/post/8057759Mon, 23 Dec 2019 14:41:16 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 14:39:27 GMT]]>Hej Sukkeralf, tak for links og super detektivarbejde. Ærgerligt at den ene blev lukket ned, men spændende med PDL1/PDL1, mindes ikke at have set denne kombination før. Mon ikke også Merck snart er klar til klinikken? Nu går der heller ikke længe før topline safety data fra ZW49, det bliver meget spændende!

]]>https://dev.proinvestor.com/forum/post/8057748https://dev.proinvestor.com/forum/post/8057748Mon, 23 Dec 2019 14:39:27 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 11:16:11 GMT]]>Saniona: https://www.proinvestor.com/investornyt/651804/sanionas-partner-medix-lamnar-in-ansokan-om-nytt-lakemedel-nda-i-mexiko-for-tesofensine-vid-fetma

]]>https://dev.proinvestor.com/forum/post/8057747https://dev.proinvestor.com/forum/post/8057747Mon, 23 Dec 2019 11:16:11 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 10:33:25 GMT]]>Hej er der nogle her der kender Diamyd.

]]>https://dev.proinvestor.com/forum/post/8057757https://dev.proinvestor.com/forum/post/8057757Mon, 23 Dec 2019 10:33:25 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 09:29:18 GMT]]>Eli Lilly BsAbs PD-L1/TIM-3 hedder LY3415244 (nu droppet) og PD-1/PD-L1 hedder LY3434172

]]>https://dev.proinvestor.com/forum/post/8057745https://dev.proinvestor.com/forum/post/8057745Mon, 23 Dec 2019 09:29:18 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 09:26:51 GMT]]>Der er en chance for at Daiichi Sankyo vælger en klinisk kandidat i Q1/Q2 2020 og Celgene (nu BMS) i Q2/Q3 2020.

]]>https://dev.proinvestor.com/forum/post/8057744https://dev.proinvestor.com/forum/post/8057744Mon, 23 Dec 2019 09:26:51 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 09:24:18 GMT]]>
Checkpoint Inhibitor Bispecific Antibodies - Eli Lilly and Company

The present invention relates to antibodies that are heterodimeric and bind human PD-L1 and human PD-1, and may be useful for treating cancer alone and in combination with chemother

favicon

(www.freepatentsonline.com)

]]>https://dev.proinvestor.com/forum/post/8057746https://dev.proinvestor.com/forum/post/8057746Mon, 23 Dec 2019 09:24:18 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 09:24:01 GMT]]>
ClinicalTrials.gov

favicon

(clinicaltrials.gov)

]]>https://dev.proinvestor.com/forum/post/8057749https://dev.proinvestor.com/forum/post/8057749Mon, 23 Dec 2019 09:24:01 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 09:21:58 GMT]]>Det anden bispecifikke antistof er et PD-1/PD-L1 antistof (IND 17/1 2019) og første indlæg på clinical trials i maj 2019:

]]>https://dev.proinvestor.com/forum/post/8057743https://dev.proinvestor.com/forum/post/8057743Mon, 23 Dec 2019 09:21:58 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 09:20:58 GMT]]>Det første der kom i klinikken var PD-L1/TIM-3 (IND 9/4 2018) som Eli Lilly meddelte ved deres R&D update i juni, at det stopper i klinikken.

]]>https://dev.proinvestor.com/forum/post/8057740https://dev.proinvestor.com/forum/post/8057740Mon, 23 Dec 2019 09:20:58 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 09:20:12 GMT]]>Lassevedel96 - nu gravede jeg lige lidt mere i Eli Lilly bispecifics med Zymeworks.

]]>https://dev.proinvestor.com/forum/post/8057739https://dev.proinvestor.com/forum/post/8057739Mon, 23 Dec 2019 09:20:12 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Mon, 23 Dec 2019 08:30:38 GMT]]>God jul: https://www.proinvestor.com/index.php?p=debat_1&postid=80357

]]>https://dev.proinvestor.com/forum/post/8057737https://dev.proinvestor.com/forum/post/8057737Mon, 23 Dec 2019 08:30:38 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Sun, 22 Dec 2019 09:49:45 GMT]]>1

]]>https://dev.proinvestor.com/forum/post/8057741https://dev.proinvestor.com/forum/post/8057741Sun, 22 Dec 2019 09:49:45 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Sat, 21 Dec 2019 09:46:54 GMT]]>Genmab købte jo CD47 af Blink. Ved ikke hvad forskellen er ift FTSV ?

]]>https://dev.proinvestor.com/forum/post/8057751https://dev.proinvestor.com/forum/post/8057751Sat, 21 Dec 2019 09:46:54 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Sat, 21 Dec 2019 09:44:26 GMT]]>https://www.fortyseveninc.com/application/files/2815/7590/4763/12092019_ASH_cKIT_Poster_FINAL.pdf

]]>https://dev.proinvestor.com/forum/post/8057734https://dev.proinvestor.com/forum/post/8057734Sat, 21 Dec 2019 09:44:26 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Sat, 21 Dec 2019 09:21:54 GMT]]>God video for os amatører https://www.fortyseveninc.com/science#CD47

]]>https://dev.proinvestor.com/forum/post/8057732https://dev.proinvestor.com/forum/post/8057732Sat, 21 Dec 2019 09:21:54 GMT<![CDATA[Reply to Biotek-snakken — December 2019 on Sat, 21 Dec 2019 09:08:29 GMT]]>https://ir.fortyseveninc.com/news-releases/news-release-details/forty-seven-inc-announces-updated-data-ongoing-clinical-trial/

]]>https://dev.proinvestor.com/forum/post/8057733https://dev.proinvestor.com/forum/post/8057733Sat, 21 Dec 2019 09:08:29 GMT